Director, Global Forecasting

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Reporting directly to the Sr. Director, Global Analytics and Insights, the Director, Global Forecasting role requires strategic thinking and expertise to provide critical contributions to disease area strategy, life-cycle planning and product and portfolio decisions. This role involves developing, refining, and communicating key strategic and revenue forecast assumptions and analyses to inform and support decision-making across the organization. This role will also work directly with Regional Forecasting leads to ensure consistency in forecast approach, assumptions, and analyses. The ideal candidate will have experience working on pipeline molecules in Oncology, strong problem-solving skills, a strategic mindset, and will exhibit curiosity, flexibility, and be comfortable with ambiguity. This position would ideally be based at our headquarters in Redwood City, CA., however open to remote candidates who are willing to travel to our CA office on a regular basis. Responsibilities include: Develops and maintains long-term forecast models and scenario plans for RevMed’s products across indications. Provides portfolio level views and analyses to support organizational decision making via streamline models and consolidation processes. Communicates and aligns key internal stakeholders around key forecast assumptions. Understands complex markets, disease states, competitive landscapes, and relevant market and managed care dynamics and uses this knowledge to develop strategic forecasts and plans. Synthesizes and communicates the similarities, differences, and considerations necessary to inform Global clinical development plans. Exhibits analytical rigor in the valuation of business opportunities and the quantification of risk. Participates in cross-functional teams to gather input for functional activities, and ensure alignment. Partners closely with other Insights and Analytics functions (Market Research, Data Analytics, Competitive Intelligence) to inform the forecast. Works closely with Pipeline Marketing, Clinical Development, Portfolio Management, and Medical Affairs to support early-stage decision making. Works closely with Regional forecasting leads to ensure consistency and understand differences in forecasts. Maintains an in-depth understanding of Revolution Medicines’ diverse product offerings, competitive positioning, and the broader market dynamics shaping the industry's future. Collaborates with vendor partners to manage various deliverables and analyses. Required Skills, Experience and Education: Bachelor's degree required (MBA preferred) with 10+ years of progressive experience in a pharmaceutical, biotechnology, or strategic consulting role with 6+ years of experience in a related analytics/forecasting role. Experience developing long-range patient-based forecasts for oncology products. Experience supporting pipeline and portfolio decision making and supporting executional strategy for pipeline analytics and insights. Track record of being a collaborative team player, and adaptive to meet the needs of a growing business. Strong problem solver with experience leveraging a variety of research and analytical vendors, study designs, and building quality research